ALKERMES | DEBITO

2022Q32023Q32024Q3

	Debt	Cambiamento		Data
AbbVie	USD 67.14B		3.94B	2024-12
Acadia Pharmaceuticals	USD 0		0	2024-12
ALKERMES	USD 0		366M	2024-12
Amgen	USD 60.1B		299M	2024-12
Biogen	USD 6.3B		1.9M	2024-12
BioMarin Pharmaceutical	USD 596.24M		1.61M	2024-12
Bristol-Myers Squibb	USD 49.65B		103M	2024-12
Eli Lilly	USD 33.64B		2.52B	2024-12
Gilead Sciences	USD 26.71B		3.46B	2024-12
Intra Cellular Therapies	USD 0		0	2024-12
Ionis Pharmaceuticals	USD 1.25B		32.8M	2024-12
J&J	USD 36.63B		883M	2024-12
Malin Corporation	EUR 0		100K	2024-06
Merck	USD 37.11B		1.02B	2024-12
Neurocrine Biosciences	USD 0		0	2024-12
Otsuka Holdings	JPY 189.38B		149.6B	2024-12
Pfizer	USD 64.35B		3.35B	2024-12
Regeneron Pharmaceuticals	USD 2.7B		400K	2024-12
Vertex Pharmaceuticals	USD 112.8M		1.2M	2024-12

ALKERMES DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.